Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 63 results.
User Information
Export Records
  1. 1.   PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
  2. Floudas, Charalampos S; Goswami, Meghali; Donahue, Renee N; Strauss, Julius; Pastor, Danielle M; Redman, Jason M; Brownell, Isaac; Turkbey, Evrim B; Steinberg, Seth M; Cordes, Lisa M; Marté, Jennifer L; Khan, Maheen H; McMahon, Sheri; Lamping, Elizabeth; Manu,Michell; Manukyan,Manuk; Brough, Douglas E; Lankford, Amy; Jochems, Caroline; Schlom, Jeffrey; Gulley, James L
  3. Cancer Immunology, Immunotherapy : CII. 2025, Mar 21; 74(5): 155.
  1. 2.   Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization
  2. Becker, William; Olkhanud, Purevdorj B; Seishima, Noriko; Moreno, Paloma A; Goldfarbmuren,Kate; Maeng, Hoyoung M; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2024, Jul 01; 12(7):
  1. 3.   Recent Advances in the Development of Non-Invasive Imaging Probes for Cancer Immunotherapy
  2. Kazim,Muhammad; Yoo,Euna
  3. Angewandte Chemie (International ed. in English). 2023, Oct 16; e202310694.
  1. 4.   First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Ra, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
  2. Leidner, Rom; Conlon, Kevin; McNeel, Douglas G; Wang-Gillam, Andrea; Gupta, Sumati; Wesolowski, Robert; Chaudhari, Monica; Hassounah, Nadia; Lee, Jong Bong; Ho Lee, Lang; O'Keeffe, Jessica A; Lewis, Nancy; Pavlakis,George; Thompson, John A
  3. Journal for Immunotherapy of Cancer. 2023, Oct; 11(10):
  1. 5.   CD47-Dependent Regulation of Immune Checkpoint Gene Expression and MYCN mRNA Splicing in Murine CD8 and Jurkat T Cells
  2. Kaur, Sukhbir; Awad, Duha; Finney, Richard P; Meyer, Thomas J; Singh, Satya P; Cam, Margaret C; Karim,Baktiar; Warner,Andrew; Roberts, David D
  3. International Journal of Molecular Sciences. 2023, Jan 30; 24(3):
  1. 6.   Context-Dependent Function of Long Noncoding RNA PURPL in Transcriptome Regulation during p53 Activation
  2. Hartford, Corrine Corrina R; Shrestha, Roshan L; Pongor, Lorinc; Zhao,Yongmei; Chen, Xiongfong; Fromont,Caroline; Chaudhary, Ritu; Li, Xiao Ling; Pasterczyk, Katherine R; Kumar, Ravi; Muys, Bruna R; Tsitsipatis, Dimitrios; Chari,Raj; Gorospe, Myriam; Aladjem, Mirit I; Khan, Javed; Basrai, Munira A; Grammatikakis, Ioannis; Lal, Ashish
  3. Molecular and Cellular Biology. 2022, Nov 07; 42(12): e0028922.
  1. 7.   NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
  2. Salomé, Bérengère; Sfakianos, John P; Ranti, Daniel; Daza, Jorge; Bieber, Christine; Charap, Andrew; Hammer, Christian; Banchereau, Romain; Farkas, Adam M; Ruan, Dan Fu; Izadmehr, Sudeh; Geanon, Daniel; Kelly, Geoffrey; de Real, Ronaldo M; Lee, Brian; Beaumont, Kristin G; Shroff, Sanjana; Wang, Yuanshuo A; Wang, Ying-Chih; Thin, Tin Htwe; Garcia-Barros, Monica; Hegewisch-Solloa, Everardo; Mace, Emily M; Wang, Li; O'Donnell, Timothy; Chowell, Diego; Fernandez-Rodriguez, Ruben; Skobe, Mihaela; Taylor, Nicole; Kim-Schulze, Seunghee; Sebra, Robert P; Palmer, Doug; Clancy-Thompson, Eleanor; Hammond, Scott; Kamphorst, Alice O; Malmberg, Karl-Johan; Marcenaro, Emanuela; Romero, Pedro; Brody, Rachel; Viard,Mathias; Yuki,Yuko; Martin,Pat; Carrington,Mary; Mehrazin, Reza; Wiklund, Peter; Mellman, Ira; Mariathasan, Sanjeev; Zhu, Jun; Galsky, Matthew D; Bhardwaj, Nina; Horowitz, Amir
  3. Cancer Cell. 2022, Sep 12; 40(9): 1027-1043.e9.
  1. 8.   Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissue
  2. Richardson, Zuwena A; Deleage,Claire; Tutuka, Candani S A; Walkiewicz, Marzena; Del Río-Estrada, Perla M; Pascoe, Rachel D; Evans, Vanessa A; Reyesteran, Gustavo; Gonzales, Michael; Roberts-Thomson, Samuel; González-Navarro, Mauricio; Torres-Ruiz, Fernanda; Estes, Jacob D; Lewin, Sharon R; Cameron, Paul U
  3. Journal of Immunological Methods. 2021, Dec 01; 113198.
  1. 9.   The deubiquitinating enzyme USP37 enhances CHK1 activity to promote the cellular response to replication stress
  2. Stromberg, Benjamin R.; Singh, Mayank; Torres, Adrian E.; Burrows, Amy C.; Pal, Debjani; Insinna, Christine; Rhee, Yosup; Dickson, Andrew S.; Westlake,Christopher; Summers, Matthew K.
  3. The Journal of Biological Chemistry. 2021, Oct; 297(4):
  1. 10.   Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
  2. Krug, Karsten; Jaehnig, Eric J; Satpathy, Shankha; Blumenberg, Lili; Karpova, Alla; Anurag, Meenakshi; Miles, George; Mertins, Philipp; Geffen, Yifat; Tang, Lauren C; Heiman, David I; Cao, Song; Maruvka, Yosef E; Lei, Jonathan T; Huang, Chen; Kothadia, Ramani B; Colaprico, Antonio; Birger, Chet; Wang, Jarey; Dou, Yongchao; Wen, Bo; Shi, Zhiao; Liao, Yuxing; Wiznerowicz, Maciej; Wyczalkowski, Matthew A; Chen, Xi Steven; Kennedy, Jacob J; Paulovich, Amanda G; Thiagarajan,Mathangi; Kinsinger, Christopher R; Hiltke, Tara; Boja, Emily S; Mesri, Mehdi; Robles, Ana I; Rodriguez, Henry; Westbrook, Thomas F; Ding, Li; Getz, Gad; Clauser, Karl R; Fenyö, David; Ruggles, Kelly V; Zhang, Bing; Mani, D R; Carr, Steven A; Ellis, Matthew J; Gillette, Michael A
  3. Cell. 2020, NOV 25; 183(5): 1436-+.
  1. 11.   Overproduction of a dominant mutant of the conserved Era GTPase inhibits cell division in Escherichia coli
  2. Zhou, Xiaomei; Peters, Howard K; Li,Xintian; Costantino,Nina; Kumari,Vandana; Shi,Genbin; Tu, Chao; Cameron, Todd A; Haeusser, Daniel P; Vega, Daniel E; Ji, Xinhua; Margolin, William; Court,Don
  3. Journal of bacteriology. 2020, NOV; 202(21): pii: JB.00342-20.
  1. 12.   Robust Expansion of HIV CAR T Cells Following Antigen Boosting in ART-Suppressed Nonhuman Primates
  2. Rust, Blake J; Kean, Leslie S; Colonna, Lucrezia; Brandenstein, Katherine; Poole, Nikhita Hegde; Obenza, Willimark; Enstrom, Mark R; Maldini, Colby R; Ellis, Gavin I; Fennessey,Christine; Huang, Meei-Li; Keele, Brandon F; Jerome, Keith; Riley, James L; Kiem, Hans-Peter; Peterson, Christopher William
  3. Blood. 2020, OCT 8; 136(15): 1722-1734.
  1. 13.   Metabolic but not transcriptional regulation by PKM2 is important for Natural Killer cell responses
  2. Walls,Jessica; Subleski,Jeff; Palmieri,Erika; Gonzalez-Cotto,Marieli; Gardiner, Clair M; McVicar,Daniel; Finlay, David K
  3. eLife. 2020, Aug 19; 9: pii: e59166.
  1. 14.   Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
  2. Merino, Diana M; McShane, Lisa M; Fabrizio, David; Funari, Vincent; Chen, Shu-Jen; White, James R; Wenz, Paul; Baden, Jonathan; Barrett, J Carl; Chaudhary, Ruchi; Chen,Li; Chen, Wangjuh Sting; Cheng, Jen-Hao; Cyanam, Dinesh; Dickey, Jennifer S; Gupta, Vikas; Hellmann, Matthew; Helman, Elena; Li, Yali; Maas, Joerg; Papin, Arnaud; Patidar,Rajesh; Quinn, Katie J; Rizvi, Naiyer; Tae, Hongseok; Ward, Christine; Xie, Mingchao; Zehir, Ahmet; Zhao, Chen; Dietel, Manfred; Stenzinger, Albrecht; Stewart, Mark; Allen, Jeff
  3. Journal for immunotherapy of cancer. 2020, Mar; 8(1): pii: e000147..
  1. 15.   rhIL-15 and anti-PD-L1 combination therapy expands a CXCR3+PD1-/low CD8 T cell subset in SIV-infected rhesus macaques
  2. Chen, Ping; Chen, Hui; Moussa, Maha; Cheng, Jie; Li, Tong; Qin, Jing; Lifson,Jeffrey; Sneller, Michael C; Krymskaya,Ludmila; Godin, Steven; Lane, H Clifford; Catalfamo, Marta
  3. The Journal of infectious diseases. 2020, Feb 15; 221(4): 523-533.
  1. 16.   Haspin-dependent and independent effects of the kinase inhibitor 5-Iodotubercidin on self-renewal and differentiation
  2. Karanika, Eleftheria; Soupsana, Katerina; Christogianni, Anastasia; Stellas,Dimitris; Klinakis, Apostolos; Politou, Anastasia S; Georgatos, Spyros
  3. Scientific reports. 2020, Jan 14; 10(1): 232.
  1. 17.   Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy
  2. Zheng, Lin; Chen, Zibo; Kawakami, Masanori; Chen, Yulong; Roszik, Jason; Mustachio, Lisa Maria; Kurie, Jonathan M; Villalobos, Pamela; Lu, Wei; Behren, Carmen; Mino, Barbara; Solis, Luisa M; Silvester, Jennifer; Thu, Kelsie L; Cescon, David W; Rodriguez-Canales, Jaime; Wistuba, Ignacio I; Mak, Tak W; Liu, Xi; Dmitrovsky,Ethan
  3. Molecular cancer therapeutics. 2019, OCT; 18(10): 1775-1786.
  1. 18.   Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study
  2. Thomas, Anish; Vilimas, Rasa; Trindade, Christopher; Erwin-Cohen,Rebecca; Roper, Nitin; Xi, Liqiang; Krishnasamy, Venkatesh; Levy, Elliot; Mammen, Andy; Nichols, Samantha; Chen, Yuanbin; Velcheti, Vamsidhar; Yin, Faye; Szabo, Eva; Pommier, Yves; Steinberg, Seth M; Trepel, Jane B; Raffeld, Mark; Young,Howard; Khan, Javed; Hewitt, Stephen; Lee, Jung-Min
  3. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2019, AUG; 14(8): 1447-1457.
  1. 19.   A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses
  2. Zimmer, Alexandra S; Nichols,Erin; Cimino-Mathews, Ashley; Peer, Cody; Cao, Liang; Lee, Min-Jung; Kohn, Elise C; Annunziata, Christina M; Lipkowitz, Stanley; Trepel, Jane B; Sharma, Rajni; Mikkilineni, Lekha; Gatti-Mays, Margaret; Figg, William D; Houston, Nicole D; Lee, Jung-Min
  3. Journal for immunotherapy of cancer. 2019, Jul 25; 7(1): 197.
  1. 20.   Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage Markers
  2. Wilsker,Deborah; Barrett, Allison M.; Dull,Angie; Lawrence,Scott; Hollingshead,Melinda; Chen, Alice; Kummar, Shivaani; Parchment,Ralph; Doroshow, James H.; Kinders,Robert
  3. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019, MAY 15; 25(10): 3084-3095.
  1. 21.   A new HIV-1 Rev structure optimizes interaction with target RNA (RRE) for nuclear export
  2. Watts, Norman R; Eren, Elif; Zhuang, Xiaolei; Wang, Yun-Xing; Steven, Alasdair C; Wingfield, Paul T
  3. Journal of Structural Biology. 2018, Aug; 203(2): 102-108.
  1. 22.   Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
  2. Ranjan, Surabhi; Quezado, Martha; Garren, Nancy; Boris, Lisa; Siegel, Christine; Lopes Abath Neto, Osorio; Theeler, Brett J; Park, Deric M; Nduom, Edjah; Zaghloul, Kareem A; Gilbert, Mark R; Wu, Jing
  3. BMC Cancer. 2018, Mar 01; 18(1): 239.
  1. 23.   Aurora-A promotes the establishment of spindle assembly checkpoint by priming the Haspin-Aurora-B feedback loop in late G2 phase
  2. Yu, Fazhi; Jiang, Ya; Lu, Lucy; Cao, Mimi; Qiao, Yulong; Liu, Xing; Liu, Dan; Van Dyke, Terry; Wang, Fangwei; Yao, Xuebiao; Guo, Jing; Yang, Zhenye
  3. CELL DISCOVERY. 2017, JAN 10; 3
  1. 24.   CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
  2. Zoppoli, G.; Solier, S.; Reinhold, W. C.; Liu, H.; Connelly, J. W.; Monks, A.; Shoemaker, R. H.; Abaan, O. D.; Davis, S. R.; Meltzer, P. S.; Doroshow, J. H.; Pommier, Y.
  3. Oncogene. 2012, Jan; 31(4): 403-418.
  1. 25.   Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy
  2. Lountos, G. T.; Jobson, A. G.; Tropea, J. E.; Self, C. R.; Zhang, G. T.; Pommier, Y.; Shoemaker, R. H.; Waugh, D. S.
  3. Journal of Structural Biology. 2011, Dec; 176(3): 292-301.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel